International Journal For Multidisciplinary Research

E-ISSN: 2582-2160   •   Impact Factor: 9.24

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Call for Paper Volume 7, Issue 6 (November-December 2025) Submit your research before last 3 days of December to publish your research paper in the issue of November-December.
Submit Research Paper Join as a Reviewer

Plagiarism is checked by the leading plagiarism checker TurnItIn

Call for Paper

Volume 7 Issue 6
November-December 2025

Submit your research paper

Indexing Partners
Academia Advanced Sciences Index Bielefeld Academic Search Engine CiteSeer DRJI Google Scholar Independent Search Engine & Directory Network ISI (International Scientific Indexing) Issuu Mendeley Research Networks
RefSeek ResearcherId - Thomson Reuters ResearchGate Scirus Scribd Semantic Scholar UTeM - Universiti Teknikal Malaysia Melaka Wiki for Call for Papers WorldCat Zenodo

Advances in Long-Acting Injectable Drug Delivery: Formulation Science, Emerging Technologies, and Future Perspectives

Author(s) Mr. THEYANESHWARAN P, Dr. DEVI DAMAYANTHI R, Ms. DEEPTHI D, Ms. SOWMIYA P
Country India
Abstract Long-acting injectable (LAI) drug delivery systems are a cornerstone of chronic disease management, offering sustained therapeutic concentrations and improved patient adherence. These formulations establish intramuscular or subcutaneous depots to provide controlled drug release, thereby minimizing dosing frequency and pharmacokinetic variability. This comprehensive review articulates the evolution of LAI platforms, from legacy oil-based solutions to advanced biodegradable polymeric microspheres (PLGA), in situ forming gels, lipid-based carriers, and nanosuspensions. The formulation principles, technical advantages, and manufacturing challenges for each technology are critically analyzed. Core drug release mechanisms, including polymer erosion, matrix diffusion, and particle dissolution, are detailed. Furthermore, advanced strategies to manipulate in vivo clearance and extend therapeutic half-life, such as PEGylation, lipidation, and Fc/HSA fusion, are synthesized. A significant focus is placed on product characterization, emphasizing the challenges in developing predictive in vitro release (IVR) methods. Key quality attributes (CQAs) and regulatory pathways are also examined. Finally, emerging technologies, including stimuli-responsive systems and AI-assisted design, are explored to outline future perspectives for enhancing the therapeutic precision and clinical utility of LAIs.
Keywords Long-acting injectables, sustained release formulations, PLGA microspheres, depot formulations, nanocarriers, biodegradable polymers, lipid-based LAIs, pharmacokinetics
Field Medical / Pharmacy
Published In Volume 7, Issue 6, November-December 2025
Published On 2025-11-03
DOI https://doi.org/10.36948/ijfmr.2025.v07i06.59694
Short DOI https://doi.org/g99qb7
View / Download PDF File

Share this



E-ISSN 2582-2160
CrossRef

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads
Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 7 Isu 5Cover Page Vol 7 Isu 4Cover Page Vol 7 Isu 3

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA Open Access

About IJFMR
Fees & Payment
Current Issue
Publication Archive 		Submit Research Paper
Track Submission Status
Publication Guidelines
Publication Ethics
Peer Review & Plagiarism 		Join as a Reviewer
Editors & Reviewers
Reviewer Referral Program
Get Reviewer Membership Certi. 		Website/Journal Policies
Usage Policy
Content Policies
Privacy Policy
Contact Us +91-9687-828-838 editor@ijfmr.com